Are you using real-world evidence?

Parexel’s experts offer a roadmap and best practices for current RWE applications across three development arenas:

  • Early asset planning
  • Clinical development: Meeting regulatory expectations
  • Medical marketplace: Demonstrating value in the real world

In each section of this playbook, we highlight examples of recent Parexel projects that illustrate the power of RWE to improve decision-making and to drive cost- and times-saving development strategies.


Open PDF

Return to Insights Center

Related Insights

Podcast

RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry

Jun 16, 2022

Blog

Summary and assessment of EMA’s reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle

Mar 7, 2024

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Blog

Using ethical AI to streamline HEOR

Jan 26, 2024

Article

Lessons from China and the United States on the use of RWE in regulatory submissions

Jul 19, 2021

Blog

Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions

May 16, 2022

Article

New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle

May 10, 2022

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Blog

Regulatory acceptability of AI: Current perspectives

Mar 7, 2024

Blog

Summary and assessment: Using Artificial Intelligence & Machine Learning in the Development of Drug & Biological Products: Discussion Paper and Request for Feedback (FDA)

Mar 7, 2024